Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium

Overview

cited authors

Spigel, David R.; Hainsworth, John D.; Shipley, Dianna L.; Mekhail, Tarek M.; Zubkus, John D.; Waterhouse, David M.; Daniel, Davey B.; Burris, Howard A., III; Greco, F. Anthony

authors

Mekhail, Tarek M., MD

Publication Date

March 1, 2018

webpage

Web of Science

published in

LUNG CANCER Journal

Research

keywords

Amrubicin
Carboplatin
Pegfilgrastim
SCLC

Additional Document Info

start page

end page

volume

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.